nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC15A2—multiple sclerosis	0.45	0.823	CbGaD
Cephalexin—SLC47A1—Mitoxantrone—multiple sclerosis	0.18	0.496	CbGbCtD
Cephalexin—ALB—multiple sclerosis	0.0968	0.177	CbGaD
Cephalexin—CYP2D6—Fingolimod—multiple sclerosis	0.0297	0.0819	CbGbCtD
Cephalexin—ALB—Prednisone—multiple sclerosis	0.0235	0.0648	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—multiple sclerosis	0.0199	0.0548	CbGbCtD
Cephalexin—CYP3A4—Fingolimod—multiple sclerosis	0.0189	0.0521	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—multiple sclerosis	0.0138	0.0382	CbGbCtD
Cephalexin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0122	0.0335	CbGbCtD
Cephalexin—ALB—Methotrexate—multiple sclerosis	0.0118	0.0325	CbGbCtD
Cephalexin—CYP3A4—Triamcinolone—multiple sclerosis	0.00921	0.0254	CbGbCtD
Cephalexin—CYP3A4—Mitoxantrone—multiple sclerosis	0.00886	0.0245	CbGbCtD
Cephalexin—CYP3A4—Betamethasone—multiple sclerosis	0.0079	0.0218	CbGbCtD
Cephalexin—CYP3A4—Prednisolone—multiple sclerosis	0.0078	0.0215	CbGbCtD
Cephalexin—CYP3A4—Prednisone—multiple sclerosis	0.00736	0.0203	CbGbCtD
Cephalexin—CYP2D6—Dexamethasone—multiple sclerosis	0.00723	0.02	CbGbCtD
Cephalexin—CYP3A4—Dexamethasone—multiple sclerosis	0.0046	0.0127	CbGbCtD
Cephalexin—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00314	0.275	CbGpPWpGaD
Cephalexin—Cefazolin—PON1—multiple sclerosis	0.000536	0.096	CrCbGaD
Cephalexin—Oxacillin—SLC15A2—multiple sclerosis	0.000457	0.0819	CrCbGaD
Cephalexin—Cefuroxime—SLC15A2—multiple sclerosis	0.000426	0.0764	CrCbGaD
Cephalexin—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000424	0.0371	CbGpPWpGaD
Cephalexin—Azidocillin—SLC15A2—multiple sclerosis	0.000375	0.0672	CrCbGaD
Cephalexin—Cefixime—SLC15A2—multiple sclerosis	0.000369	0.0661	CrCbGaD
Cephalexin—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000351	0.0307	CbGpPWpGaD
Cephalexin—Ceftazidime—SLC15A2—multiple sclerosis	0.000347	0.0621	CrCbGaD
Cephalexin—Cefdinir—SLC15A2—multiple sclerosis	0.00034	0.061	CrCbGaD
Cephalexin—Cefaclor—SLC15A2—multiple sclerosis	0.000337	0.0604	CrCbGaD
Cephalexin—Amoxicillin—SLC15A2—multiple sclerosis	0.000323	0.0579	CrCbGaD
Cephalexin—Cefradine—SLC15A2—multiple sclerosis	0.000323	0.0579	CrCbGaD
Cephalexin—Cefadroxil—SLC15A2—multiple sclerosis	0.000306	0.0548	CrCbGaD
Cephalexin—Ampicillin—SLC15A2—multiple sclerosis	0.000287	0.0514	CrCbGaD
Cephalexin—Cefotaxime—SLC15A2—multiple sclerosis	0.000266	0.0478	CrCbGaD
Cephalexin—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00025	0.0219	CbGpPWpGaD
Cephalexin—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000245	0.0215	CbGpPWpGaD
Cephalexin—Urticaria—Cladribine—multiple sclerosis	0.000231	0.00311	CcSEcCtD
Cephalexin—Abdominal pain—Cladribine—multiple sclerosis	0.00023	0.0031	CcSEcCtD
Cephalexin—Body temperature increased—Cladribine—multiple sclerosis	0.00023	0.0031	CcSEcCtD
Cephalexin—Cefalotin—SLC15A2—multiple sclerosis	0.00023	0.0412	CrCbGaD
Cephalexin—Skin disorder—Azathioprine—multiple sclerosis	0.00023	0.00309	CcSEcCtD
Cephalexin—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000226	0.00304	CcSEcCtD
Cephalexin—Infestation—Methylprednisolone—multiple sclerosis	0.000226	0.00304	CcSEcCtD
Cephalexin—Benzylpenicillin—SLC15A2—multiple sclerosis	0.000223	0.04	CrCbGaD
Cephalexin—Haemoglobin—Prednisolone—multiple sclerosis	0.000222	0.00299	CcSEcCtD
Cephalexin—Haemorrhage—Prednisolone—multiple sclerosis	0.000221	0.00297	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000216	0.0029	CcSEcCtD
Cephalexin—Hypersensitivity—Cladribine—multiple sclerosis	0.000215	0.00289	CcSEcCtD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00021	0.0184	CbGpPWpGaD
Cephalexin—Leukopenia—Mitoxantrone—multiple sclerosis	0.00021	0.00282	CcSEcCtD
Cephalexin—Asthenia—Cladribine—multiple sclerosis	0.000209	0.00281	CcSEcCtD
Cephalexin—Pruritus—Cladribine—multiple sclerosis	0.000206	0.00277	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000205	0.00275	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000204	0.00275	CcSEcCtD
Cephalexin—Haemoglobin—Triamcinolone—multiple sclerosis	0.000204	0.00275	CcSEcCtD
Cephalexin—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000204	0.00274	CcSEcCtD
Cephalexin—Haemorrhage—Triamcinolone—multiple sclerosis	0.000203	0.00273	CcSEcCtD
Cephalexin—Convulsion—Mitoxantrone—multiple sclerosis	0.000203	0.00273	CcSEcCtD
Cephalexin—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000203	0.00273	CcSEcCtD
Cephalexin—Hallucination—Methylprednisolone—multiple sclerosis	0.000202	0.00271	CcSEcCtD
Cephalexin—Arthralgia—Mitoxantrone—multiple sclerosis	0.0002	0.00269	CcSEcCtD
Cephalexin—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000199	0.00268	CcSEcCtD
Cephalexin—Diarrhoea—Cladribine—multiple sclerosis	0.000199	0.00268	CcSEcCtD
Cephalexin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000195	0.00262	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—multiple sclerosis	0.000194	0.00261	CcSEcCtD
Cephalexin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000194	0.0026	CcSEcCtD
Cephalexin—Confusional state—Mitoxantrone—multiple sclerosis	0.000193	0.0026	CcSEcCtD
Cephalexin—Dizziness—Cladribine—multiple sclerosis	0.000193	0.00259	CcSEcCtD
Cephalexin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000191	0.00257	CcSEcCtD
Cephalexin—Neutropenia—Prednisone—multiple sclerosis	0.000188	0.00252	CcSEcCtD
Cephalexin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000187	0.00252	CcSEcCtD
Cephalexin—Abdominal pain—Azathioprine—multiple sclerosis	0.000187	0.00252	CcSEcCtD
Cephalexin—Body temperature increased—Azathioprine—multiple sclerosis	0.000187	0.00252	CcSEcCtD
Cephalexin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000186	0.0025	CcSEcCtD
Cephalexin—Haemoglobin—Dexamethasone—multiple sclerosis	0.000185	0.00249	CcSEcCtD
Cephalexin—Haemoglobin—Betamethasone—multiple sclerosis	0.000185	0.00249	CcSEcCtD
Cephalexin—Vomiting—Cladribine—multiple sclerosis	0.000185	0.00249	CcSEcCtD
Cephalexin—Haemorrhage—Dexamethasone—multiple sclerosis	0.000184	0.00248	CcSEcCtD
Cephalexin—Haemorrhage—Betamethasone—multiple sclerosis	0.000184	0.00248	CcSEcCtD
Cephalexin—Rash—Cladribine—multiple sclerosis	0.000184	0.00247	CcSEcCtD
Cephalexin—Hallucination—Betamethasone—multiple sclerosis	0.000184	0.00247	CcSEcCtD
Cephalexin—Hallucination—Dexamethasone—multiple sclerosis	0.000184	0.00247	CcSEcCtD
Cephalexin—Dermatitis—Cladribine—multiple sclerosis	0.000183	0.00247	CcSEcCtD
Cephalexin—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000183	0.00246	CcSEcCtD
Cephalexin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000183	0.016	CbGpPWpGaD
Cephalexin—Headache—Cladribine—multiple sclerosis	0.000182	0.00245	CcSEcCtD
Cephalexin—Mental disorder—Methylprednisolone—multiple sclerosis	0.000178	0.00239	CcSEcCtD
Cephalexin—Angioedema—Prednisolone—multiple sclerosis	0.000176	0.00236	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—multiple sclerosis	0.000175	0.00236	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000175	0.00235	CcSEcCtD
Cephalexin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000174	0.00235	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000174	0.00235	CcSEcCtD
Cephalexin—Nausea—Cladribine—multiple sclerosis	0.000173	0.00233	CcSEcCtD
Cephalexin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000169	0.00227	CcSEcCtD
Cephalexin—Convulsion—Prednisolone—multiple sclerosis	0.000167	0.00224	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—multiple sclerosis	0.000166	0.00223	CcSEcCtD
Cephalexin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000165	0.0145	CbGpPWpGaD
Cephalexin—Fatigue—Mitoxantrone—multiple sclerosis	0.000165	0.00222	CcSEcCtD
Cephalexin—Diarrhoea—Azathioprine—multiple sclerosis	0.000162	0.00218	CcSEcCtD
Cephalexin—Angioedema—Triamcinolone—multiple sclerosis	0.000162	0.00217	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—multiple sclerosis	0.000161	0.00217	CcSEcCtD
Cephalexin—Angioedema—Methylprednisolone—multiple sclerosis	0.000161	0.00217	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—multiple sclerosis	0.000161	0.00216	CcSEcCtD
Cephalexin—Hallucination—Prednisone—multiple sclerosis	0.00016	0.00215	CcSEcCtD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00016	0.014	CbGpPWpGaD
Cephalexin—Pancytopenia—Methotrexate—multiple sclerosis	0.000159	0.00214	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—multiple sclerosis	0.000158	0.00212	CcSEcCtD
Cephalexin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000158	0.00212	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000157	0.00211	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—multiple sclerosis	0.000157	0.00211	CcSEcCtD
Cephalexin—Dizziness—Azathioprine—multiple sclerosis	0.000157	0.00211	CcSEcCtD
Cephalexin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000157	0.00211	CcSEcCtD
Cephalexin—Convulsion—Triamcinolone—multiple sclerosis	0.000153	0.00206	CcSEcCtD
Cephalexin—Convulsion—Methylprednisolone—multiple sclerosis	0.000153	0.00206	CcSEcCtD
Cephalexin—Urticaria—Mitoxantrone—multiple sclerosis	0.000152	0.00205	CcSEcCtD
Cephalexin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000151	0.00204	CcSEcCtD
Cephalexin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000151	0.00204	CcSEcCtD
Cephalexin—Vomiting—Azathioprine—multiple sclerosis	0.000151	0.00203	CcSEcCtD
Cephalexin—Arthralgia—Methylprednisolone—multiple sclerosis	0.00015	0.00202	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—multiple sclerosis	0.00015	0.00201	CcSEcCtD
Cephalexin—Infestation—Methotrexate—multiple sclerosis	0.00015	0.00201	CcSEcCtD
Cephalexin—Rash—Azathioprine—multiple sclerosis	0.000149	0.00201	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000149	0.00201	CcSEcCtD
Cephalexin—Dermatitis—Azathioprine—multiple sclerosis	0.000149	0.00201	CcSEcCtD
Cephalexin—Headache—Azathioprine—multiple sclerosis	0.000148	0.002	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000148	0.00199	CcSEcCtD
Cephalexin—Angioedema—Betamethasone—multiple sclerosis	0.000147	0.00197	CcSEcCtD
Cephalexin—Angioedema—Dexamethasone—multiple sclerosis	0.000147	0.00197	CcSEcCtD
Cephalexin—Confusional state—Methylprednisolone—multiple sclerosis	0.000145	0.00195	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—multiple sclerosis	0.000145	0.00195	CcSEcCtD
Cephalexin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000144	0.00194	CcSEcCtD
Cephalexin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000144	0.00194	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000141	0.0019	CcSEcCtD
Cephalexin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000141	0.0019	CcSEcCtD
Cephalexin—Cefpiramide—ALB—multiple sclerosis	0.000141	0.0253	CrCbGaD
Cephalexin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000141	0.0019	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—multiple sclerosis	0.000141	0.00189	CcSEcCtD
Cephalexin—Nausea—Azathioprine—multiple sclerosis	0.000141	0.00189	CcSEcCtD
Cephalexin—Skin disorder—Methylprednisolone—multiple sclerosis	0.00014	0.00188	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—multiple sclerosis	0.00014	0.00188	CcSEcCtD
Cephalexin—Convulsion—Dexamethasone—multiple sclerosis	0.000139	0.00187	CcSEcCtD
Cephalexin—Convulsion—Betamethasone—multiple sclerosis	0.000139	0.00187	CcSEcCtD
Cephalexin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000138	0.0121	CbGpPWpGaD
Cephalexin—Asthenia—Mitoxantrone—multiple sclerosis	0.000137	0.00185	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—multiple sclerosis	0.000135	0.00181	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—multiple sclerosis	0.000134	0.00181	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—multiple sclerosis	0.000134	0.00181	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000133	0.00178	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—multiple sclerosis	0.000132	0.00177	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000132	0.00177	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000131	0.00177	CcSEcCtD
Cephalexin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000131	0.00176	CcSEcCtD
Cephalexin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000131	0.00176	CcSEcCtD
Cephalexin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000131	0.00176	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000129	0.00174	CcSEcCtD
Cephalexin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000129	0.00173	CcSEcCtD
Cephalexin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000129	0.00173	CcSEcCtD
Cephalexin—Agitation—Prednisone—multiple sclerosis	0.000128	0.00173	CcSEcCtD
Cephalexin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000128	0.00173	CcSEcCtD
Cephalexin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000128	0.00173	CcSEcCtD
Cephalexin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000128	0.0112	CbGpPWpGaD
Cephalexin—Angioedema—Prednisone—multiple sclerosis	0.000128	0.00172	CcSEcCtD
Cephalexin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000127	0.00171	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000127	0.00171	CcSEcCtD
Cephalexin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000127	0.00171	CcSEcCtD
Cephalexin—Urticaria—Prednisolone—multiple sclerosis	0.000125	0.00168	CcSEcCtD
Cephalexin—Fatigue—Triamcinolone—multiple sclerosis	0.000125	0.00167	CcSEcCtD
Cephalexin—Fatigue—Methylprednisolone—multiple sclerosis	0.000124	0.00167	CcSEcCtD
Cephalexin—Cefonicid—ALB—multiple sclerosis	0.000123	0.0221	CrCbGaD
Cephalexin—Vomiting—Mitoxantrone—multiple sclerosis	0.000122	0.00164	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—multiple sclerosis	0.000121	0.00163	CcSEcCtD
Cephalexin—Convulsion—Prednisone—multiple sclerosis	0.000121	0.00163	CcSEcCtD
Cephalexin—Rash—Mitoxantrone—multiple sclerosis	0.000121	0.00162	CcSEcCtD
Cephalexin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000121	0.00162	CcSEcCtD
Cephalexin—Headache—Mitoxantrone—multiple sclerosis	0.00012	0.00161	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000119	0.00161	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000119	0.00161	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—multiple sclerosis	0.000119	0.0016	CcSEcCtD
Cephalexin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000119	0.0016	CcSEcCtD
Cephalexin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000119	0.0016	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000118	0.00159	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000118	0.00158	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—multiple sclerosis	0.000118	0.00158	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000116	0.00156	CcSEcCtD
Cephalexin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000116	0.0101	CbGpPWpGaD
Cephalexin—Dyspepsia—Betamethasone—multiple sclerosis	0.000115	0.00155	CcSEcCtD
Cephalexin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000115	0.00155	CcSEcCtD
Cephalexin—Urticaria—Triamcinolone—multiple sclerosis	0.000115	0.00154	CcSEcCtD
Cephalexin—Urticaria—Methylprednisolone—multiple sclerosis	0.000114	0.00154	CcSEcCtD
Cephalexin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000114	0.00154	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000114	0.00153	CcSEcCtD
Cephalexin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000114	0.00153	CcSEcCtD
Cephalexin—Nausea—Mitoxantrone—multiple sclerosis	0.000114	0.00153	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000113	0.00152	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000113	0.00152	CcSEcCtD
Cephalexin—Fatigue—Betamethasone—multiple sclerosis	0.000113	0.00152	CcSEcCtD
Cephalexin—Fatigue—Dexamethasone—multiple sclerosis	0.000113	0.00152	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—multiple sclerosis	0.000112	0.00151	CcSEcCtD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000112	0.00977	CbGpPWpGaD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000111	0.00976	CbGpPWpGaD
Cephalexin—Skin disorder—Prednisone—multiple sclerosis	0.000111	0.00149	CcSEcCtD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00011	0.00963	CbGpPWpGaD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00011	0.00963	CbGpPWpGaD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00011	0.00961	CbGpPWpGaD
Cephalexin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000108	0.00145	CcSEcCtD
Cephalexin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000108	0.00145	CcSEcCtD
Cephalexin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000107	0.00144	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000107	0.00144	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000107	0.00937	CbGpPWpGaD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000107	0.00935	CbGpPWpGaD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000107	0.00935	CbGpPWpGaD
Cephalexin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000106	0.00143	CcSEcCtD
Cephalexin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000106	0.00143	CcSEcCtD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000105	0.00923	CbGpPWpGaD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000105	0.00923	CbGpPWpGaD
Cephalexin—Leukopenia—Methotrexate—multiple sclerosis	0.000105	0.00141	CcSEcCtD
Cephalexin—Urticaria—Betamethasone—multiple sclerosis	0.000104	0.0014	CcSEcCtD
Cephalexin—Urticaria—Dexamethasone—multiple sclerosis	0.000104	0.0014	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000104	0.0014	CcSEcCtD
Cephalexin—Dizziness—Prednisolone—multiple sclerosis	0.000104	0.0014	CcSEcCtD
Cephalexin—Asthenia—Triamcinolone—multiple sclerosis	0.000104	0.00139	CcSEcCtD
Cephalexin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000104	0.00139	CcSEcCtD
Cephalexin—Abdominal pain—Betamethasone—multiple sclerosis	0.000104	0.00139	CcSEcCtD
Cephalexin—Body temperature increased—Betamethasone—multiple sclerosis	0.000104	0.00139	CcSEcCtD
Cephalexin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000104	0.00139	CcSEcCtD
Cephalexin—Asthenia—Methylprednisolone—multiple sclerosis	0.000103	0.00139	CcSEcCtD
Cephalexin—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000103	0.00899	CbGpPWpGaD
Cephalexin—Pruritus—Triamcinolone—multiple sclerosis	0.000102	0.00137	CcSEcCtD
Cephalexin—Pruritus—Methylprednisolone—multiple sclerosis	0.000102	0.00137	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—multiple sclerosis	0.000101	0.00136	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—multiple sclerosis	0.0001	0.00135	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—multiple sclerosis	9.95e-05	0.00134	CcSEcCtD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	9.92e-05	0.00869	CbGpPWpGaD
Cephalexin—Rash—Prednisolone—multiple sclerosis	9.9e-05	0.00133	CcSEcCtD
Cephalexin—Dermatitis—Prednisolone—multiple sclerosis	9.89e-05	0.00133	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.88e-05	0.00133	CcSEcCtD
Cephalexin—Diarrhoea—Methylprednisolone—multiple sclerosis	9.86e-05	0.00133	CcSEcCtD
Cephalexin—Fatigue—Prednisone—multiple sclerosis	9.84e-05	0.00132	CcSEcCtD
Cephalexin—Headache—Prednisolone—multiple sclerosis	9.84e-05	0.00132	CcSEcCtD
Cephalexin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	9.73e-05	0.00852	CbGpPWpGaD
Cephalexin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	9.65e-05	0.00845	CbGpPWpGaD
Cephalexin—Confusional state—Methotrexate—multiple sclerosis	9.62e-05	0.00129	CcSEcCtD
Cephalexin—Dizziness—Triamcinolone—multiple sclerosis	9.55e-05	0.00128	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—multiple sclerosis	9.54e-05	0.00128	CcSEcCtD
Cephalexin—Dizziness—Methylprednisolone—multiple sclerosis	9.53e-05	0.00128	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—multiple sclerosis	9.4e-05	0.00126	CcSEcCtD
Cephalexin—Asthenia—Betamethasone—multiple sclerosis	9.4e-05	0.00126	CcSEcCtD
Cephalexin—Asthenia—Dexamethasone—multiple sclerosis	9.4e-05	0.00126	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—multiple sclerosis	9.35e-05	0.00126	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—multiple sclerosis	9.34e-05	0.00126	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—multiple sclerosis	9.33e-05	0.00126	CcSEcCtD
Cephalexin—Nausea—Prednisolone—multiple sclerosis	9.33e-05	0.00125	CcSEcCtD
Cephalexin—Pruritus—Dexamethasone—multiple sclerosis	9.27e-05	0.00125	CcSEcCtD
Cephalexin—Pruritus—Betamethasone—multiple sclerosis	9.27e-05	0.00125	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—multiple sclerosis	9.26e-05	0.00125	CcSEcCtD
Cephalexin—Vomiting—Triamcinolone—multiple sclerosis	9.18e-05	0.00124	CcSEcCtD
Cephalexin—Vomiting—Methylprednisolone—multiple sclerosis	9.16e-05	0.00123	CcSEcCtD
Cephalexin—Rash—Triamcinolone—multiple sclerosis	9.11e-05	0.00122	CcSEcCtD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.11e-05	0.00798	CbGpPWpGaD
Cephalexin—Dermatitis—Triamcinolone—multiple sclerosis	9.1e-05	0.00122	CcSEcCtD
Cephalexin—Rash—Methylprednisolone—multiple sclerosis	9.09e-05	0.00122	CcSEcCtD
Cephalexin—Dermatitis—Methylprednisolone—multiple sclerosis	9.08e-05	0.00122	CcSEcCtD
Cephalexin—Urticaria—Prednisone—multiple sclerosis	9.07e-05	0.00122	CcSEcCtD
Cephalexin—Headache—Triamcinolone—multiple sclerosis	9.05e-05	0.00122	CcSEcCtD
Cephalexin—Headache—Methylprednisolone—multiple sclerosis	9.03e-05	0.00121	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—multiple sclerosis	9.02e-05	0.00121	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—multiple sclerosis	9.02e-05	0.00121	CcSEcCtD
Cephalexin—Diarrhoea—Betamethasone—multiple sclerosis	8.97e-05	0.00121	CcSEcCtD
Cephalexin—Diarrhoea—Dexamethasone—multiple sclerosis	8.97e-05	0.00121	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.69e-05	0.00117	CcSEcCtD
Cephalexin—Dizziness—Betamethasone—multiple sclerosis	8.67e-05	0.00117	CcSEcCtD
Cephalexin—Dizziness—Dexamethasone—multiple sclerosis	8.67e-05	0.00117	CcSEcCtD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.65e-05	0.00758	CbGpPWpGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.65e-05	0.00758	CbGpPWpGaD
Cephalexin—Nausea—Triamcinolone—multiple sclerosis	8.58e-05	0.00115	CcSEcCtD
Cephalexin—Nausea—Methylprednisolone—multiple sclerosis	8.56e-05	0.00115	CcSEcCtD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.45e-05	0.0074	CbGpPWpGaD
Cephalexin—Hypersensitivity—Prednisone—multiple sclerosis	8.41e-05	0.00113	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—multiple sclerosis	8.4e-05	0.00113	CcSEcCtD
Cephalexin—ALB—Platelet degranulation—PLEK—multiple sclerosis	8.37e-05	0.00733	CbGpPWpGaD
Cephalexin—Vomiting—Betamethasone—multiple sclerosis	8.33e-05	0.00112	CcSEcCtD
Cephalexin—Vomiting—Dexamethasone—multiple sclerosis	8.33e-05	0.00112	CcSEcCtD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.31e-05	0.00728	CbGpPWpGaD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	8.28e-05	0.00725	CbGpPWpGaD
Cephalexin—Rash—Dexamethasone—multiple sclerosis	8.26e-05	0.00111	CcSEcCtD
Cephalexin—Rash—Betamethasone—multiple sclerosis	8.26e-05	0.00111	CcSEcCtD
Cephalexin—Dermatitis—Dexamethasone—multiple sclerosis	8.25e-05	0.00111	CcSEcCtD
Cephalexin—Dermatitis—Betamethasone—multiple sclerosis	8.25e-05	0.00111	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.23e-05	0.00111	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—multiple sclerosis	8.22e-05	0.00111	CcSEcCtD
Cephalexin—Headache—Dexamethasone—multiple sclerosis	8.21e-05	0.0011	CcSEcCtD
Cephalexin—Headache—Betamethasone—multiple sclerosis	8.21e-05	0.0011	CcSEcCtD
Cephalexin—Asthenia—Prednisone—multiple sclerosis	8.19e-05	0.0011	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.11e-05	0.0071	CbGpPWpGaD
Cephalexin—Pruritus—Prednisone—multiple sclerosis	8.07e-05	0.00109	CcSEcCtD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	7.98e-05	0.00699	CbGpPWpGaD
Cephalexin—Feeling abnormal—Methotrexate—multiple sclerosis	7.86e-05	0.00106	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—multiple sclerosis	7.81e-05	0.00105	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.8e-05	0.00105	CcSEcCtD
Cephalexin—Nausea—Betamethasone—multiple sclerosis	7.78e-05	0.00105	CcSEcCtD
Cephalexin—Nausea—Dexamethasone—multiple sclerosis	7.78e-05	0.00105	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—multiple sclerosis	7.58e-05	0.00102	CcSEcCtD
Cephalexin—Dizziness—Prednisone—multiple sclerosis	7.55e-05	0.00102	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—multiple sclerosis	7.54e-05	0.00101	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—multiple sclerosis	7.54e-05	0.00101	CcSEcCtD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.52e-05	0.00658	CbGpPWpGaD
Cephalexin—Vomiting—Prednisone—multiple sclerosis	7.26e-05	0.000976	CcSEcCtD
Cephalexin—Rash—Prednisone—multiple sclerosis	7.2e-05	0.000968	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—multiple sclerosis	7.19e-05	0.000967	CcSEcCtD
Cephalexin—Headache—Prednisone—multiple sclerosis	7.15e-05	0.000962	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—multiple sclerosis	7.03e-05	0.000945	CcSEcCtD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.98e-05	0.00611	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.98e-05	0.00611	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.89e-05	0.00603	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.89e-05	0.00603	CbGpPWpGaD
Cephalexin—Asthenia—Methotrexate—multiple sclerosis	6.84e-05	0.00092	CcSEcCtD
Cephalexin—Nausea—Prednisone—multiple sclerosis	6.78e-05	0.000912	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—multiple sclerosis	6.75e-05	0.000908	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—multiple sclerosis	6.53e-05	0.000878	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.41e-05	0.00561	CbGpPWpGaD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.36e-05	0.00557	CbGpPWpGaD
Cephalexin—Dizziness—Methotrexate—multiple sclerosis	6.31e-05	0.000848	CcSEcCtD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.27e-05	0.00549	CbGpPWpGaD
Cephalexin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	6.26e-05	0.00548	CbGpPWpGaD
Cephalexin—Ampicillin—ALB—multiple sclerosis	6.17e-05	0.0111	CrCbGaD
Cephalexin—Vomiting—Methotrexate—multiple sclerosis	6.06e-05	0.000816	CcSEcCtD
Cephalexin—Rash—Methotrexate—multiple sclerosis	6.01e-05	0.000809	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—multiple sclerosis	6.01e-05	0.000808	CcSEcCtD
Cephalexin—Headache—Methotrexate—multiple sclerosis	5.97e-05	0.000804	CcSEcCtD
Cephalexin—Cefazolin—ALB—multiple sclerosis	5.96e-05	0.0107	CrCbGaD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.9e-05	0.00517	CbGpPWpGaD
Cephalexin—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	5.89e-05	0.00516	CbGpPWpGaD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.81e-05	0.00509	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.67e-05	0.00496	CbGpPWpGaD
Cephalexin—Nausea—Methotrexate—multiple sclerosis	5.67e-05	0.000762	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.66e-05	0.00496	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.66e-05	0.00496	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.66e-05	0.00496	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.57e-05	0.00488	CbGpPWpGaD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.25e-05	0.0046	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.04e-05	0.00441	CbGpPWpGaD
Cephalexin—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	5e-05	0.00438	CbGpPWpGaD
Cephalexin—Cefalotin—ALB—multiple sclerosis	4.95e-05	0.00887	CrCbGaD
Cephalexin—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	4.7e-05	0.00412	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.63e-05	0.00405	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	4.6e-05	0.00403	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	4.6e-05	0.00403	CbGpPWpGaD
Cephalexin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	4.59e-05	0.00402	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.53e-05	0.00397	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.53e-05	0.00397	CbGpPWpGaD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.38e-05	0.00384	CbGpPWpGaD
Cephalexin—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.3e-05	0.00377	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.29e-05	0.00376	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.22e-05	0.0037	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.21e-05	0.00368	CbGpPWpGaD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.01e-05	0.00352	CbGpPWpGaD
Cephalexin—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	3.92e-05	0.00343	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	3.86e-05	0.00338	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.82e-05	0.00335	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	3.71e-05	0.00325	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL4—multiple sclerosis	3.71e-05	0.00325	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.66e-05	0.0032	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	3.62e-05	0.00317	CbGpPWpGaD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.6e-05	0.00315	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.39e-05	0.00297	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.34e-05	0.00292	CbGpPWpGaD
Cephalexin—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.26e-05	0.00286	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	3.24e-05	0.00284	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.23e-05	0.00283	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.19e-05	0.00279	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CD58—multiple sclerosis	3.1e-05	0.00271	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MERTK—multiple sclerosis	3.1e-05	0.00271	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SELPLG—multiple sclerosis	3.1e-05	0.00271	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.02e-05	0.00264	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.01e-05	0.00263	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.01e-05	0.00263	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3e-05	0.00263	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.96e-05	0.0026	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.96e-05	0.0026	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.95e-05	0.00258	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—ICAM1—multiple sclerosis	2.95e-05	0.00258	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	2.76e-05	0.00241	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.67e-05	0.00234	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—CCL2—multiple sclerosis	2.64e-05	0.00231	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.52e-05	0.00221	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	2.46e-05	0.00215	CbGpPWpGaD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.4e-05	0.0021	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.34e-05	0.00205	CbGpPWpGaD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.29e-05	0.00201	CbGpPWpGaD
Cephalexin—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.28e-05	0.002	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IFNG—multiple sclerosis	2.24e-05	0.00196	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.23e-05	0.00195	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.19e-05	0.00192	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.14e-05	0.00187	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.14e-05	0.00187	CbGpPWpGaD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.13e-05	0.00186	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.09e-05	0.00183	CbGpPWpGaD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.09e-05	0.00183	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.04e-05	0.00179	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL1B—multiple sclerosis	2e-05	0.00175	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL2—multiple sclerosis	1.99e-05	0.00174	CbGpPWpGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.95e-05	0.0017	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLEK—multiple sclerosis	1.91e-05	0.00168	CbGpPWpGaD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.89e-05	0.00166	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.78e-05	0.00156	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.78e-05	0.00156	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.66e-05	0.00145	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.59e-05	0.00139	CbGpPWpGaD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.58e-05	0.00138	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.57e-05	0.00138	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TNF—multiple sclerosis	1.45e-05	0.00127	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.44e-05	0.00126	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SRM—multiple sclerosis	1.35e-05	0.00118	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SELE—multiple sclerosis	1.35e-05	0.00118	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.33e-05	0.00117	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.31e-05	0.00115	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.29e-05	0.00113	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.27e-05	0.00111	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.27e-05	0.00111	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL6—multiple sclerosis	1.17e-05	0.00103	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.16e-05	0.00102	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.16e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.15e-05	0.00101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SRM—multiple sclerosis	1.12e-05	0.000977	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.08e-05	0.000946	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.06e-05	0.000931	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.03e-05	0.000906	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—ITGA4—multiple sclerosis	9.75e-06	0.000854	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IFNB1—multiple sclerosis	9.68e-06	0.000848	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.61e-06	0.000842	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP27B1—multiple sclerosis	9.52e-06	0.000834	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP24A1—multiple sclerosis	9.52e-06	0.000834	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.3e-06	0.000815	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	9.3e-06	0.000815	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPC5—multiple sclerosis	8.71e-06	0.000763	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.02e-06	0.000702	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	7.86e-06	0.000689	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	7.86e-06	0.000689	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	7.58e-06	0.000664	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SRM—multiple sclerosis	7.29e-06	0.000639	CbGpPWpGaD
Cephalexin—ALB—Metabolism—RRM1—multiple sclerosis	7.21e-06	0.000632	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPC5—multiple sclerosis	7.19e-06	0.00063	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.76e-06	0.000592	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2RA—multiple sclerosis	6.66e-06	0.000583	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—RRM1—multiple sclerosis	5.96e-06	0.000522	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.91e-06	0.000518	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.79e-06	0.000508	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.6e-06	0.00049	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.14e-06	0.00045	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.14e-06	0.00045	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.81e-06	0.000421	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.7e-06	0.000412	CbGpPWpGaD
Cephalexin—ALB—Metabolism—BCHE—multiple sclerosis	4.14e-06	0.000363	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—multiple sclerosis	3.9e-06	0.000342	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.89e-06	0.000341	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.42e-06	0.0003	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—multiple sclerosis	3.05e-06	0.000267	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MAPK1—multiple sclerosis	2.99e-06	0.000262	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOE—multiple sclerosis	2.49e-06	0.000218	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.24e-06	0.000196	CbGpPWpGaD
Cephalexin—ALB—Metabolism—POMC—multiple sclerosis	2.14e-06	0.000188	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOE—multiple sclerosis	2.06e-06	0.00018	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—POMC—multiple sclerosis	1.77e-06	0.000155	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—multiple sclerosis	1.61e-06	0.000141	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOE—multiple sclerosis	1.35e-06	0.000118	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—POMC—multiple sclerosis	1.16e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—multiple sclerosis	1.05e-06	9.23e-05	CbGpPWpGaD
